StockData
Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc. (CLRB) KPIs and segments

CLRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$0.92−0.09 (-8.88%)

Close on Nov 17, 2026Market cap $8.70MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Cellectar Biosciences's business

Coming soon

This tab will track the numbers specific to Cellectar Biosciences's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?